Yi Huang

Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆

Xiaohua Wu, Jianqing Zhu, Rutie Yin et al. · Annals of Oncology · 2021 · 206 citations

Medicine, Oncology, Pharmacology +15

Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial

Xiangyu Gao, Nong Xu, Ziyu Li et al. · The Lancet Oncology · 2023 · 197 citations

Pharmacy, Oncology, Pharmacology +16

Deep learning-enabled pelvic ultrasound images for accurate diagnosis of ovarian cancer in China: a retrospective, multicentre, diagnostic study

Yue Gao, Shaoqing Zeng, Xiaoyan Xu et al. · The Lancet Digital Health · 2022 · 179 citations · Full text

Medicine, Gynecology, Oncology +17

Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer

Ning Li, Jianqing Zhu, Rutie Yin et al. · JAMA Oncology · 2023 · 159 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China

Xiaohua Wu, Yang Sun, Hongying Yang et al. · The Lancet · 2024 · 102 citations

Medicine, Oncology, Pharmacology +13